Spots Global Cancer Trial Database for castrate resistant
Every month we try and update this database with for castrate resistant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gallium-68 Citrate PET Used in Prostate Cancer | NCT02391025 | Prostatic Neopl... | Gallium-68 citr... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer | NCT01393730 | Prostate Cancer | Abiraterone ace... Dutasteride Prednisone | 18 Years - | Dana-Farber Cancer Institute | |
| GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer | NCT01420861 | Prostate Cancer | GTx-758 | 18 Years - 80 Years | GTx | |
| INTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) | NCT02730338 | Metastatic Pros... | High intensity ... Psychosocial su... | 18 Years - | Movember Foundation | |
| Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer | NCT03098836 | Prostate Cancer | ARN-509 Abiraterone Ace... Prednisone | 18 Years - | Duke University | |
| Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | NCT01706458 | Prostate Cancer | sipuleucel-T DNA Vaccine | 18 Years - | University of Wisconsin, Madison | |
| A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer | NCT01685489 | Prostatic Neopl... | Docetaxel, PSK® Docetaxel, Plac... | 18 Years - | Bastyr University | |
| Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer | NCT03098836 | Prostate Cancer | ARN-509 Abiraterone Ace... Prednisone | 18 Years - | Duke University | |
| Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer | NCT01313559 | Castrate Resist... Chemotherapy Na... Prostate Cancer | Pasireotide Everolimus Laboratory biom... | 18 Years - | Thomas Jefferson University | |
| Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | NCT01706458 | Prostate Cancer | sipuleucel-T DNA Vaccine | 18 Years - | University of Wisconsin, Madison | |
| Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | NCT02887976 | Prostate Cancer | SoluMatrix™ Abi... Methylprednisol... | 18 Years - | GU Research Network, LLC | |
| Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology | NCT02022904 | Prostate Cancer | Near infrared (... | 18 Years - | Duke University | |
| INTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) | NCT02730338 | Metastatic Pros... | High intensity ... Psychosocial su... | 18 Years - | Movember Foundation | |
| Gallium-68 Citrate PET Used in Prostate Cancer | NCT02391025 | Prostatic Neopl... | Gallium-68 citr... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| BKM120+Abiraterone Acetate for Metastatic CRPC | NCT01741753 | Prostate Cancer | BKM120 Abiraterone Prednisone | 18 Years - | Dana-Farber Cancer Institute | |
| Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis | NCT02097303 | Prostate Cancer | Concurrent use ... | 18 Years - | Carolina Research Professionals, LLC | |
| Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer | NCT01940276 | Prostate Cancer | Abiraterone ace... Prednisone | 18 Years - | Duke University | |
| Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology | NCT02022904 | Prostate Cancer | Near infrared (... | 18 Years - | Duke University | |
| Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology | NCT02022904 | Prostate Cancer | Near infrared (... | 18 Years - | Duke University | |
| GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer | NCT01420861 | Prostate Cancer | GTx-758 | 18 Years - 80 Years | GTx | |
| PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy | NCT01144897 | Castrate Resist... Prostate Cancer | PET Acetate sca... Carbon-11 label... | 18 Years - | University of Iowa | |
| INTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) | NCT02730338 | Metastatic Pros... | High intensity ... Psychosocial su... | 18 Years - | Movember Foundation | |
| A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer | NCT01685489 | Prostatic Neopl... | Docetaxel, PSK® Docetaxel, Plac... | 18 Years - | Bastyr University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
